全文获取类型
收费全文 | 62203篇 |
免费 | 4611篇 |
国内免费 | 182篇 |
专业分类
耳鼻咽喉 | 678篇 |
儿科学 | 1657篇 |
妇产科学 | 1312篇 |
基础医学 | 7729篇 |
口腔科学 | 1537篇 |
临床医学 | 6311篇 |
内科学 | 12439篇 |
皮肤病学 | 966篇 |
神经病学 | 5673篇 |
特种医学 | 1963篇 |
外国民族医学 | 1篇 |
外科学 | 9935篇 |
综合类 | 949篇 |
一般理论 | 60篇 |
预防医学 | 5455篇 |
眼科学 | 1747篇 |
药学 | 3987篇 |
中国医学 | 59篇 |
肿瘤学 | 4538篇 |
出版年
2022年 | 437篇 |
2021年 | 972篇 |
2020年 | 642篇 |
2019年 | 964篇 |
2018年 | 1157篇 |
2017年 | 869篇 |
2016年 | 991篇 |
2015年 | 1166篇 |
2014年 | 1661篇 |
2013年 | 2719篇 |
2012年 | 3703篇 |
2011年 | 3935篇 |
2010年 | 2262篇 |
2009年 | 2101篇 |
2008年 | 3693篇 |
2007年 | 3788篇 |
2006年 | 3791篇 |
2005年 | 3955篇 |
2004年 | 3758篇 |
2003年 | 3489篇 |
2002年 | 3342篇 |
2001年 | 663篇 |
2000年 | 559篇 |
1999年 | 757篇 |
1998年 | 835篇 |
1997年 | 673篇 |
1996年 | 581篇 |
1995年 | 568篇 |
1994年 | 503篇 |
1993年 | 495篇 |
1992年 | 516篇 |
1991年 | 493篇 |
1990年 | 466篇 |
1989年 | 428篇 |
1988年 | 380篇 |
1987年 | 351篇 |
1986年 | 398篇 |
1985年 | 391篇 |
1984年 | 493篇 |
1983年 | 469篇 |
1982年 | 622篇 |
1981年 | 557篇 |
1980年 | 490篇 |
1979年 | 343篇 |
1978年 | 331篇 |
1977年 | 347篇 |
1976年 | 335篇 |
1975年 | 276篇 |
1974年 | 283篇 |
1973年 | 284篇 |
排序方式: 共有10000条查询结果,搜索用时 375 毫秒
1.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
2.
3.
Philip S. Vendittelli Bassent Botros Howard S. Rosman Viren Govindaraju Anwar Zaitoun Tariq S. Marroush 《The American journal of the medical sciences》2019,357(4):333-337
Coronary embolism (CE) is an uncommon and unique cause of acute myocardial infarction. In this report, we review 216 cases of CE including 2 new cases from our institution. The mean patient age was 52.5 years and 62% of the patients were males. Chest pain was the most common presenting symptom followed by dyspnea, and the most commonly affected vessel was the left anterior descending artery. Leading etiologies of the embolus were atrial fibrillation, septic emboli, and iatrogenic causes. Treatment approaches varied with thrombus aspiration being used in 30% of cases. In-hospital mortality rate was 36% and 13% of the cases were complicated by cerebrovascular accident. CE is a unique pathology that leads to acute myocardial infarction. It portends a high mortality rate and requires a high level of suspicion as symptoms may be misleading. Further research is needed in order to improve recognition and management and to lower associated mortality. 相似文献
4.
The human visual system is amenable to a number of adaptive processes; one such process, or collection of processes, is the adaptation to blur. Blur adaptation can be observed as an improvement in vision under degraded conditions, and these changes occur relatively rapidly following exposure to blur. The potential important future directions of this research area and the clinical implications of blur adaptation are discussed. 相似文献
5.
6.
7.
Edward J. Holland Walter O. Whitley Kenneth Sall Stephen S. Lane Aparna Raychaudhuri Steven Y. Zhang 《Current medical research and opinion》2016,32(10):1759-1765
Objective: Report efficacy findings from three clinical trials (one phase 2 and two phase 3 [OPUS-1, OPUS-2]) of lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease (DED).Research design and methods: Three 84-day, randomized, double-masked, placebo-controlled trials. Adults (≥18 years) with DED were randomized (1:1) to lifitegrast 5.0% or matching placebo. Changes from baseline to day 84 in signs and symptoms of DED were analyzed.Main outcome measures: Phase 2, pre-specified endpoint: inferior corneal staining score (ICSS; 0–4); OPUS-1, coprimary endpoints: ICSS and visual-related function subscale (0–4 scale); OPUS-2, coprimary endpoints: ICSS and eye dryness score (EDS, VAS; 0–100).Results: Fifty-eight participants were randomized to lifitegrast 5.0% and 58 to placebo in the phase 2 trial; 293 to lifitegrast and 295 to placebo in OPUS-1; 358 to lifitegrast and 360 to placebo in OPUS-2. In participants with mild-to-moderate baseline DED symptomatology, lifitegrast improved ICSS versus placebo in the phase 2 study (treatment effect, 0.35; 95% CI, 0.05–0.65; p?=?0.0209) and OPUS-1 (effect, 0.24; 95% CI, 0.10–0.38; p?=?0.0007). Among more symptomatic participants (baseline EDS ≥40, recent artificial tear use), lifitegrast improved EDS versus placebo in a post hoc analysis of OPUS-1 (effect, 13.34; 95% CI, 2.35–24.33; nominal p?=?0.0178) and in OPUS-2 (effect, 12.61; 95% CI, 8.51–16.70; p?<?0.0001).Limitations: Trials were conducted over 12 weeks; efficacy beyond this period was not assessed.Conclusions: Across three trials, lifitegrast improved ICSS in participants with mild-to-moderate baseline symptomatology in two studies, and EDS in participants with moderate-to-severe baseline symptomatology in two studies. Based on the overall findings from these trials, lifitegrast shows promise as a new treatment option for signs and symptoms of DED. 相似文献
8.
9.
10.
IntroductionInterprofessional learning (IPL) is a vital aspect of training in radiation oncology professions, yet is rarely delivered to those professionals who work most closely together in clinical practice. Scenario-based learning using simulation facilities provides a unique opportunity to facilitate this learning and this project aimed to determine the impact and value of this initiative.MethodsSmall groups comprising post-graduate diploma pre-registration therapeutic radiographers, medical physics trainees and radiation oncology registrars were challenged with 4 plausible and challenging radiotherapy scenarios within an academic simulation centre. Pre- and post-event completion of the “Readiness for Interprofessional Learning Scale” measured impact and a Likert-style survey gathered feedback from participants.ResultsThe session increased participants' teamwork and collaboration skills as well as strengthening professional identities. Participants reported high levels of enjoyment related to collaborative working, communication and observing other professionals deploying their technical skills and specialist knowledge.ConclusionAlthough beneficial, simulated scenarios offering equal opportunities for engagement across the professions are challenging to plan and timetabling issues between the 3 groups present significant difficulties. The safe environment and unique opportunity for these groups to learn together was particularly well received and future oncology-specific simulated scenario sessions are planned with larger cohorts.Implications for practiceSimulated scenario training can be used to improve team working across the radiotherapy interprofessional team and may have wider use in other specialist interdisciplinary team development. 相似文献